FDA GI Division Director Justice Is Returning To FDA From Genentech
Executive Summary
Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September
You may also be interested in...
GI Division Director Justice Returns To Oncology Review Management
Former Gastrointestinal-& Coagulation Drug Products Division Director Robert Justice, MD, is returning to FDA's oncology product review team as deputy director of the Division of Therapeutic Biological Oncology Products
GI Division Director Justice Returns To Oncology Review Management
Former Gastrointestinal-& Coagulation Drug Products Division Director Robert Justice, MD, is returning to FDA's oncology product review team as deputy director of the Division of Therapeutic Biological Oncology Products
FDA Office Of Drug Safety Director-Designate Is ODE III Deputy Raczkowski
FDA Office of Drug Safety Director-designate Victor Raczkowski, MD, brings hands-on experience with the application of risk-management techniques from the review of GlaxoSmithKline's Lotronex